What to Expect When Medicare and Pharma Finally Negotiate Drug Prices

Tradeoffs

Innhold levert av Tradeoffs. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Tradeoffs eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

6M ago 26:18

MP3•Episoder hjem

Last fall, the federal government named its first 10 targets for historic drug price negotiations with big pharma. Those negotiations are expected to heat up this February when federal officials make their opening price offers.

This week, we offer a refresher on how this negotiation process will work and the impact it could have.

Guests:

Anton Avanceña, PhD, Assistant Professor of Health Outcomes, University of Texas

Darius Lakdawalla, PhD, Professor of Pharmaceutical Economics and Public Policy, University of Southern California

Lauren Neves, JD, Deputy Vice President, PhRMA

Steve Pearson, MD, MSc, Founder and President, Institute for Clinical and Economic Review (ICER)

Ben Rome, MD, MPH, physician and researcher, Harvard Medical School

Meena Seshamani, MD, PhD, Deputy Administrator, Centers for Medicare and Medicaid Services

Leslie Walker, Senior Producer/Reporter, Tradeoffs

Learn more and read a full transcript on our website.

Support this type of journalism today, with a gift.

Hosted on Acast. See acast.com/privacy for more information.

279 episoder

#News #Health Industry #Health and Well-Being #Health Care #Science #Tradeoffs